Andrew Combs

Companies

• Prelude Therapeutics IncEVP, Head of Chemistry Sep 24, 2020 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PTPrelude Therapeutics Inc PRLD480,123 shares²$1.6M at $3.37Mar 25, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 25, 2025Bought 100,000 shares at $0.69 of Prelude Therapeutics Inc²
• Dec 23, 2024Bought 60,000 shares at $1.37 of Prelude Therapeutics Inc³
• Dec 20, 2024Bought 3,075 shares at $1.15 of Prelude Therapeutics Inc³
• Mar 31, 2022Exercised options 36,062 shares at $1.89 of Prelude Therapeutics Inc⁴
• Dec 14, 2021Bought 4,000 shares at $11.60 of Prelude Therapeutics Inc⁵
• Dec 13, 2021Bought 4,000 shares at $12.12 of Prelude Therapeutics Inc⁵